Company: BIAF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001840
Chunk: 989

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 9B
Chunk 989
---
During
the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement”
or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Item
9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.

None.

 62 

PART
III

Item
10. Directors, Executive Officers, and Corporate Governance.

The
information required by this item of this Annual Report will be included under the caption “Directors, Executive Officers, and
Corporate Governance” in our 2025 Proxy Statement, and is incorporated by reference herein.

Item
11. Executive Compensation.

The
information required by this item of this Annual Report will be included under the caption “Executive and Director Compensation”
in our 2025 Proxy Statement, and is incorporated by reference herein.

Item
12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

The
information required by this item of this Annual Report will be included in our 2025 Proxy Statement and is incorporated by reference
herein.

Item
13. Certain Relationships and Related Transactions, and Director Independence.

The
information required by this item of this Annual Report will be included under the captions “Certain Relationships and Related
Party Transactions” and “Board of Directors and Corporate Governance – Director Independence” in our 2025 Proxy
Statement and is incorporated by reference herein.

Item
14. Principal Accountant Fees and Services.

The
information required by this item of this Annual Report will be included in our 2025 Proxy Statement and is incorporated by reference
herein.

 63 

PART
IV

Item
15. Exhibit and Financial Statement Schedules.

(a)
Financial Statements and Schedules.

See
“Index to Consolidated Financial Statements” beginning on page F-1 following the signature page as required by Part II, Item
8 of this Annual Report.

(b)
Exhibits.

    Exhibit
    Number
     
    Description

    3.1

    Certificate of Incorporation of the Registrant as filed with the Delaware Secretary of State on March 26, 2014 (incorporated by reference as Exhibit 3.1 to the Registrant’s Annual Report on Form 10-K filed with the SEC on April 1, 2024)

    3.2
     
    Amended and Restated By